Treatment and prevention of viral hepatitis in pregnancy.
Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN.
Am J Obstet Gynecol. 2022 Mar;226(3):335-346. doi: 10.1016/j.ajog.2021.09.002. Epub 2021 Sep 10.
Sofosbuvir.
[No authors listed]
2022 Feb 7. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Daclatasvir.
[No authors listed]
2022 Feb 7. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Urticaria and hepatitis.
Cribier B.
Clin Rev Allergy Immunol. 2006 Feb;30(1):25-9. doi: 10.1385/CRIAI:30:1:025.
Biomarkers in Detection of Hepatitis C Virus Infection.
Woo J, Choi Y.
Pathogens. 2024 Apr 17;13(4):331. doi: 10.3390/pathogens13040331.
Zepatier.
[No authors listed]
2022 Feb 7. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis.
Hung HY, Hung WL, Shih CL, Chen CY.
Ann Med. 2022 Dec;54(1):108-120. doi: 10.1080/07853890.2021.2012589.
Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis.
McHutchison JG, Kuo G, Houghton M, Choo QL, Redeker AG.
Gastroenterology. 1991 Oct;101(4):1117-9. doi: 10.1016/0016-5085(91)90742-4.
Hepatitis C: the clinical spectrum of disease.
Hoofnagle JH.
Hepatology. 1997 Sep;26(3 Suppl 1):15S-20S. doi: 10.1002/hep.510260703.
Course and outcome of hepatitis C.
Hoofnagle JH.
Hepatology. 2002 Nov;36(5 Suppl 1):S21-9. doi: 10.1053/jhep.2002.36227.
